The online version of this article (doi:10.1186/s12888-017-1316-0) contains supplementary material, which is available to authorized users.
The exact nature of treatment and management recommendations made, and received, for mood and anxiety disorders in a community population is unclear. In addition, there is limited evidence on the impact of recommendations on actual receipt of treatment or implementation of management strategies. We aim to describe the frequency with which specific recommendations were made and implemented; and thus assess the size of any gap between the recommendation and implementation of treatments and management strategies.
We used the Survey ‘Living with a Chronic Condition in Canada - Mood and Anxiety Disorders (SLCDC-MA), a unique crossectional survey of a large (N = 3358) and representative sample of Canadians with a diagnosed mood or anxiety disorder, which was conducted by Statistics Canada. The survey collected information on recommendations for medication, counselling, exercise, reduction of alcohol consumption, smoking cessation and reduction of street drug use. We also estimate the frequency that recommendations are made and followed, as well the impact of the prior on the latter. We consulted people with lived experience of the disorders to help interpret our results.
The results generally showed that most people would receive recommendations, almost all for antidepressant medications (94.6%), with lower proportions for the other treatment and management strategies (e.g. 62.1 and 66% for counselling and exercise). Most recommendations were implemented and had an impact on behaviour. The exception to this was smoking reduction/cessation, which was often not recommended or followed through. Other than with medication, at least 20% of the population, for each recommendation, would not have their recommendation implemented. A substantive group also exists who access treatments, and employ various management strategies, without a recommendation.
The results indicate that there is a gap between recommendations made and the implementation of treatments. However, its size varies substantially across treatments.
Additional file 1: Full description of questions asked to respondents, and restrictions applied to the answers. (DOCX 12 kb)12888_2017_1316_MOESM1_ESM.docx
Marcus MM, Yasamy T, van Ommeren M, Chisholm D, and Saxena S. “Depression: A Global Public Health Concern.” Accessed 13 Sept 2016. http://www.who.int/mental_health/management/depression/who_paper_depression_wfmh_2012.pdf.
“WHO | Depression.” http://www.who.int/mediacentre/factsheets/fs369/en/. WHO. Accessed 13 Sept 2016.
Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJL, Vos T, Whiteford HA. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013;10(11):e1001547. doi: 10.1371/journal.pmed.1001547. CrossRefPubMedPubMedCentral
Mayo-Wilson E, Dias S, Mavranezouli I, Kew K, Clark DM, Ades AE, Pilling S. Psychological and pharmacological interventions for Social anxiety disorder in adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2014;1(5):368–76. doi: 10.1016/S2215-0366(14)70329-3. CrossRefPubMedPubMedCentral
Yatham LN, Kennedy SH, O’Donovan C, Parikh S, MacQueen G, McIntyre R, Sharma V, et al. Canadian network for mood and anxiety treatments (CANMAT) guidelines for the Management of Patients with Bipolar disorder: consensus and controversies. Bipolar Disord. 2005;7(Suppl 3):5–69. doi: 10.1111/j.1399-5618.2005.00219.x. CrossRefPubMed
American Psychiatric Association. Treating Major Depressive Disorder. Available at: http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd-guide.pdf. [updated October 2010] Accessed Mar 2017.
National Institute for Clinical Excellence. Depression in adults: recognition and management. Available at: https://www.nice.org.uk/guidance/cg90. [updated April 2016] Accessed Mar 2017.
Ravindran AV, Balneaves LG, Faulkner G, Ortiz A, McIntosh D, Morehouse RL, Ravindran L, Yatham LN, Kennedy SH, Lam RW, Canadian Network for Mood and Anxiety Treatments (CANMAT), et al. Clinical guidelines for the Management of Adults with major depressive disorder: section 5. Complementary and alternative medicine treatments. Can J Psychiatry. 2016;61(9):576–87. CrossRefPubMedPubMedCentral
Scottish Intercollegiate Guidelines Network. Non-pharmacological management of depression in adults. Available at: http://sign.ac.uk/pdf/qrg114.pdf. [updated January 2010] Accessed Mar 2017.
Divac N, Marić NP, Damjanović A, Jovanović AA, Jasović-Gasić M, Prostran M. Use or underuse of therapeutic guidelines in Psychiatry? Psychiatr Danub. 2009;21(2):224–9. PubMed
Dennehy EB, Bauer MS, Perlis RH, Kogan JN, Sachs GS. Concordance with treatment guidelines for Bipolar disorder: data from the systematic treatment enhancement program for Bipolar disorder. ResearchGate. 2007;40(3):72–84.
Stiles PG, Boothroyd RA, Dhont K, Beiler PF, Green AE. Adherence to practice guidelines, clinical outcomes, and costs among Medicaid Enrollees with severe mental illnesses. Evaluation & the Health Professions, January. 2009;21 doi: 10.1177/0163278708328744.
Altınbaş K, Smith D, Oral ET. Adherence to Turkish Psychiatric Association guideline for Bipolar depression treatment in a specialized mood disorders outpatient unit. Psychiatr Danub. 2011;23(2):189–93. PubMed
Survey on Living wtih a Chronic Condition in Canada (Mood and Anxiety Disorders) Ottawa: Statistics Canada; 2013 [updated 18-10-2013].
Rothman KJ. Epidemiology. An Introduction Oxford: Oxford University Press. 2002;2002
Government of Canada, Statistics Canada. “Survey on Living with Chronic Diseases in Canada (SLCDC),” http://www23.statcan.gc.ca/imdb/p2SV.pl?Function=getSurvey&SDDS=5160. Accessed 30 Aug 2016.
Stata (version 14). Stata Corporation: College Station, TX, 2015.
INVOLVE. Briefing note seven. Available at: http://www.invo.org.uk/benefits-and-challenges-of-consultation/. Accessed Mar 2017.
“Depression in Adults: Recognition and Management | 1-Guidance | Guidance and Guidelines | NICE.” Accessed 13 Sept 2016. https://www.nice.org.uk/guidance/cg90/chapter/1-Guidance#care-of-all-people-with-depression.
Ali JS, McDermott S, Gravel RG. Recent research on immigrant health from statistics Canada's population surveys. Can J Public Health. 2004;95:I9–13. PubMed
Tiwari SK, Wang J. The epidemiology of mental and substance use-related disorders among white, Chinese, and other Asian populations in Canada. Can J Psychiatr. 2006;51:904–12. CrossRef
Bromet E, Andrade LH, Hwang I, Sampson NA, Alonso J, de Girolamo G, de Graaf R, Demyttenaere K, Hu C, Iwata N, Karam AN, Kaur J, Kostyuchenko S, Lepine JP, Levinson D, Matschinger H, Mora ME, Browne MO, Posada-Villa J, Viana MC, Williams DR, Kessler RC. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. 2011;9:90. CrossRefPubMedPubMedCentral
Patten SB, Williams JVA, Lavorato D, Wang JL, McDonald K, Bulloch A. Descriptive epidemiology of major depression in Canada in 2012. Can J Psychiatr. 2014;60:23–30. CrossRef
Government of Canada, Statistics Canada. “Same-Sex Couples and Sexual Orientation… by the Numbers,” June 23, 2015. http://www.statcan.gc.ca/eng/dai/smr08/2015/smr08_203_2015. Accessed 30 Aug 2016.
Government of Canada, Statistics Canada. “The Daily — Labour Force Survey: Year-End Review, 2014,” January 28, 2015. http://www.statcan.gc.ca/daily-quotidien/150128/dq150128a-eng.htm. Accessed 30 Aug 2016.
“Practice Guideline For The Treatment of Patients With Major Depressive Disorder.” Accessed 13 Sept 2016. http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdf.
- A comparison of recommendations and received treatment for mood and anxiety disorders in a representative national sample
Benjamin A. R. Woolf
Jeanne V. A. Williams
Dina H. Lavorato
Andrew G. M. Bulloch
Scott B. Patten
- BioMed Central
Neu im Fachgebiet Psychiatrie
Meistgelesene Bücher aus dem Fachgebiet